D
DOD Biotech PCL
SET:DOD
DOD Biotech PCL
SET:DOD
Price:
0.72
THB
-13.25%
Market Cap:
฿324.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
DOD Biotech PCL
SET:DOD
|
TH |
|
H
|
Hydration Pharmaceuticals Co Ltd
ASX:HPC
|
AU |
|
Qrf NV
F:2QR
|
BE |
|
Redcare Pharmacy NV
OTC:SHPPF
|
NL |
|
Agatos SpA
F:5JS1
|
IT |
|
Topps Tiles PLC
F:929
|
UK |
|
Altarea SCA
OTC:ATRRF
|
FR |
|
Legend Mining Ltd
ASX:LEG
|
AU |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
CN |
|
Thunder Mountain Gold Inc
OTC:THMG
|
US |
|
S
|
Sonic Healthcare Ltd
OTC:SKHCF
|
AU |
|
G
|
Goldex Resources Corp
XTSX:GDX
|
CA |
|
Summerset Group Holdings Ltd
NZX:SUM
|
NZ |
|
S
|
Song Da No5 JSC
VN:SD5
|
VN |
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 137.4m | 147m | 307.6m | 78.2m | 324.6m | 265.1m | (424.2m) | 48.9m | 40.5m | 43.4m | |
| 8.3m | 18.2m | 21.6m | 54.5m | 76.6m | 67m | 64.5m | 73.5m | 60.7m | 43m | |
| 19.3m | (527.8k) | (688.4k) | 9.7m | 6.1m | (14.6m) | 330.8m | (17.1m) | (73.7m) | (17.8m) | |
| 4.7m | 4.5m | 1.3m | 2.9m | 19.2m | 43.8m | 5m | 4.7m | 26.4m | 4.8m | |
| 619.7k | 3.5m | 3.8m | 9.5m | 9.5m | 4.7m | 4.3m | 5.3m | 199.7k | 2.7m | |
| (8.2m) | 39.8m | (263.7m) | (185.2m) | (85.1m) | (172.5m) | (101.8m) | (82.5m) | 7.4m | 22.7m | |
| 156.7m | 204.5m | 64.9m | (42.8m) | 322.2m | 145m | (130.7m) | 22.8m | 34.8m | 91.3m | |
| (116.9m) | (55.2m) | (38.1m) | (289.4m) | (127.6m) | (182.9m) | (63.3m) | (18.1m) | (22.5m) | (48.9m) | |
| — | (5m) | (695m) | 353.4m | (21.1k) | 110.6m | 1.2m | (71.7m) | 219.7m | (159.3m) | |
| (116.9m) | (60.2m) | (733.1m) | 63.9m | (127.6m) | (72.4m) | (62.1m) | (89.8m) | 197.2m | (208.2m) | |
| — | — | 994.9m | 18.2m | 0 | 20.5m | 0 | 159.4m | 0 | — | |
| 89.4m | 235.9k | (40.7m) | 75.5m | 9.5m | (75.2m) | 41.4m | (62.1m) | (71.6m) | 24.3m | |
| — | — | (261m) | (180.4m) | (143.5m) | — | — | — | — | — | |
| (160m) | (80m) | 0 | 11.1m | — | 684.9k | 20m | 7.4m | (5.3m) | (1.3m) | |
| (70.6m) | (79.8m) | 693.1m | (75.6m) | (134m) | (54m) | 61.4m | 104.7m | (76.9m) | 23m | |
| (30.8m) | 64.5m | 24.9m | (54.4m) | 60.6m | 18.7m | (131.4m) | 37.7m | 155.1m | (93.9m) | |
| 39.8m | 149.3m | 26.8m | (332.2m) | 194.6m | (37.9m) | (194m) | 4.7m | 12.3m | 42.4m |
A mature staples franchise balancing steady sales with heavier reinvestment
A mature consumer-health model with durable profits and improving cash generation
A diversified branded and industrial portfolio with durable cash generation
